Category: Artificial Intelligence

The U.S. Food and Drug Administration (FDA) has approved Opill, a non-prescription oral contraceptive tablet, for preventing pregnancy. This is the first daily oral contraceptive that can be purchased without a prescription in the United States. Opill will be available for sale at drug stores, convenience stores, grocery stores, and online, but the availability and […]

Continue Reading

Wellinks, a company specializing in digital solutions for chronic obstructive pulmonary disease (COPD), has appointed Stacie Bratcher as its new CEO. Bratcher has previously served as CEO of Jet Health and Alana Healthcare, as well as holding the position of board chair at GripAble. In her new role, Bratcher aims to leverage virtual solutions to […]

Continue Reading

French medical technology startup, Sonio, has raised $14 million in Series A funding, bringing its total funding to $20 million since its founding in 2020. Sonio’s AI platform automates ultrasound reporting, aiming to improve accuracy, speed, and efficiency for healthcare providers. The platform receives ultrasound images from any machine and processes them in the cloud […]

Continue Reading

The number of Americans affected by Alzheimer’s disease is on the rise, especially as Baby Boomers reach the age of 65. However, the lack of effective drug therapies and limited screening for cognitive decline have hindered a response to this public health crisis. Recently approved FDA drugs offer promising treatment options for Alzheimer’s, but they […]

Continue Reading

The FDA has authorized a mobile app called AspyreRx, developed by Better Therapeutics, as a treatment for type 2 diabetes. This regulatory decision creates a new class of therapies for the metabolic disorder. AspyreRx is a prescription digital therapeutic that digitizes cognitive behavioral therapy, which is already part of diabetes care. The app allows patients […]

Continue Reading

The U.S. Food and Drug Administration (FDA) has provided an update on various activities happening within the agency. One of the main focuses is the prevention of illicit xylazine from entering the United States. The FDA’s Center for Veterinary Medicine (CVM) is working in collaboration with other FDA offices and the Department of Health and […]

Continue Reading

Septerna Therapeutics has secured $150 million in Series B financing to support the development of its small molecule drug candidate for the treatment of hypoparathyroidism. The funding round was led by RA Capital Management and included participation from a range of investors, including Deep Track Capital, Goldman Sachs Asset Management, and Vertex Ventures HC, among […]

Continue Reading

UK-based immersive technology company FourPlus has secured funding from Innovate UK, the UK’s national innovation agency, to develop a mixed reality training platform for pharmaceutical companies and the healthcare sector. FourPlus already uses its immersive technology, including virtual reality experiences, in the life sciences sector for marketing, training, and workforce management. With a ₤1 million […]

Continue Reading

CellTrans, a small biotech company, has received the first FDA approval for a cell therapy for type 1 diabetes. The therapy, known as Lantidra, is intended for adults with type 1 diabetes who are unable to achieve their target blood glucose levels through regular insulin administration. Lantidra, which is made from pancreatic cells sourced from […]

Continue Reading